Characteristics

n/N

OR [95% CI]

p-value

Age range

0.2225

≤30

2/9

0.28 [0.04 - 1.18]

]30 - 60]

26/57

2.93 [0.64 - 20.86]

≥60

31/58

4.01 [0.88 - 28.54]

Sex

0.7196

Female

22/40

Male

39/85

0.84 [0.03 - 21.91]

Comorbidities

HTA

27/61

0.70 [0.34 - 1.41]

0.3240

Diabetes

26/44

1.88 [0.90 - 4]

0.0935

Obesity

3/8

0.70 [0.34 - 1.41]

0.7182

STROKE

6/12

1.05 [0.31 - 3.55]

0.9315

Cardiopathy

1/7

0.16 [0 - 0.98]

0.0955

Fever

25/47

1.32 [0.64 - 2.73]

0.4503

Dyspnea

36/71

1.18 [0.58 - 2.40]

0.6323

Hypotension

2/5

0.59 [0.07 - 3.71]

0.6675

Impaired GC

35/56

1.88 [0.78 - 4.60]

0.1667

SaO₂

30/44

2.14 [1.15 - 4.16]

0.0014

Covid-19 severity

<0.0001

Asymptomatic

0/3

-

Mild

1/7

9 [0.21 - 2.52]

Moderate

13/42

3.29 [1.08 - 2.83]

Severe

28/41

4.30 [1.44 - 3.77]

Critical

12/12

9331 [0 - +∞]

eGFR (ml/min/1.73m²)

0.0003

> 90

0/2

0.01 [0 - +∞]

]60 - 90]

5/22

0.43 [0.43 - 1.35]

]45 - 60]

4/16

0.49 [0.43 - 1.7]

]30 - 45]

7/18

0.93 [1.03 - 2.92]

]15 - 30]

12/23

1.60 [0.54 - 1.25]

≤15

30/42

2.50 [1.33 - 5.07]

Hyperglycemia

16/22

4.53 [1.67 - 13.80]

0.0036

Hepatic cytolysis

49/96

0.59 [0.19 - 1.70]

0.3395

Anemia

33/60

1.85 [0.89 - 3.90]

0.1018

Hyperkalemia

12/17

0.38 [0.09 - 1.29]

0.1107

Antibiotics

55/114

0.79 [0.24 - 2.54]

0.7750

Corticosteroids

25/39

2.46 [1.14 - 5.47]

0.0336

Anticoagulant

47/88

1.83 [0.85 - 4.02]

0.1291

Dialysis

9/17

1.20 [0.43 - 3.44]

0.7973

Length of hospitalization < 7 days

43/55

3.58 [1.95 - 7.10]

<0.0001